Answers are grounded in this paper and cite their sources.
Background For suitable patients, an arteriovenous fistula (AVF) is the favored hemodialysis vascular access for its long-term patency and lower complication rate. However, the clinical characteristics associated with prevalent AVF use, including whether their relationships are nonlinear, involve interactions, or vary across patient groups, remain incompletely understood. We aimed to use explainable machine learning to identify routine clinical variables associated with AVF use and explore their contributions to model output. Methods In this retrospective cross-sectional study, 2,106 maintenance hemodialysis patients were included. Five machine learning algorithms: Logistic Regression, Random Forest (RF), Extreme Gradient Boosting (XGBoost), Adaptive Boosting, and Support Vector Machines, were developed to separate AVF from non-AVF use. Each model used model-specific feature selection from 25 candidate variables and training-fitted preprocessing. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and three repeats of five-fold stratified cross-validation. Shapley Additive Explanations analysis was used to identify important features and quantify their contributions. Separate logistic analyses examined nonlinear terms, selected interactions, and adjusted disease-by-creatinine associations. Results Among the tested models, XGBoost and RF achieved internal-holdout AUCs of 0.832 (95%CI, 0.793–0.867) and 0.820 (95%CI, 0.780–0.859), respectively. Their mean repeated-cross-validation AUCs were 0.796 and 0.790. Serum creatinine, age, primary disease, dialysis vintage, and gender were the most important SHAP features. The holdout top-five features remained among the top five in all assessed validation folds in both models. Selected interactions improved cross-validation discrimination: the AUC difference beyond nonlinear additive terms was 0.0088 (0.0051–0.0128), while 0.0006 (-0.0069–0.0080) on the internal holdout. Calibration results varied across models. Conclusion Routine clinical variables helped distinguish prevalent AVF from non-AVF use. SHAP characterized feature contributions across models and validation folds. These findings may inform clinical assessment of AVF use and support the development of individualized vascular-access guidance.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: